Event-Driven Stocks

Aclarion, Inc.

ACONNasdaq

Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs4 good3 warning1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21
Revenue$75,730$45,724$75,404$60,444$60,292
Operating income−$7.1M−$5.5M−$4.9M−$5.6M−$3.0M
Net income−$7.2M−$7.0M−$4.9M−$7.1M−$5.0M
Total assets$13.7M$2.1M$2.5M$2.9M$1.9M
Total liabilities$837,287$1.2M
Equity$12.8M$970,057−$727,995$2.2M−$12.8M
EPS (diluted)$-13.61$-7478.90$-79782.00$-19.61$-6.58
Shares out.582,3717.2M7.9M491,345905,685

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−9312.5%
Net margin
−9551.9%
Return on equity
−56.4%
Return on assets
−52.9%
Return on capital (ROCE)
−54.9%
Liabilities / assets
6.1%
Debt / equity
0.07×
Book value / share
$22.04
Revenue growth (YoY)
65.6%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
4.23safe
Accruals / assets
0.5%clean
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
60
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 severe3 warning4 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026198,5364.0-24.5%
Apr 30, 2026262,9461.5+33.0%
Apr 15, 2026197,7191.5+39.0%
Mar 31, 2026142,2783.1-0.3%
Mar 13, 2026142,7421.5-14.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)